chromocell.com (CHRO) - Dodolan perusahaan
Chromocell Therapeutics faces threats due to a lack of revenue and a dependence on investments. The company's sales volume demonstrates current demand dynamics, where the 0.00 mark reflects the latest data. Management is currently focusing on initial analgesic tests, while the company strives to develop safe non-opioid treatments for chronic pain.
Rincian analitis perusahaan Chromocell Therapeutics Corp. (CHRO)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Chromocell Therapeutics|CHRO - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Chromocell Therapeutics Corp|CHRO - Gunggung utang perusahaan|Utang marang modal buku Chromocell Therapeutics Corp.|CHRO - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Chromocell Therapeutics|Likuiditas darurat chromocell.com
- data bathi bisnis lan rasio investasi:
CHRO - Bathi resik perusahaan|Penghasilan resik sing dikarepake Chromocell Therapeutics|CHRO - Pangali P/E|Pangali Forward P/E chromocell.com|CHRO - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Chromocell Therapeutics Corp.|CHRO - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Chromocell Therapeutics|CHRO - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan chromocell.com|CHRO - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Chromocell Therapeutics
- indikator volume dodolan lan pendapatan:
Analisis umum perusahaan:Chromocell, CHRO
Revenue reflects the aggregate cash flow from asset realization, serving as an integral indicator of management efficiency and fundamental business stability. The daily price action on the sales revenue chart for Chromocell Therapeutics (CHRO) demonstrates the capitalization's sensitivity to financial results, which is critical for Chromocell Therapeutics (CHRO) as outsourcing production to CMO facilities minimizes operating expenses and the risks of capacity downtime.
Pesaing wigati
Total pendapatan perusahaan Biogen Idec BIIB|Pendapatan lan volume dodolan NBIX|Dodolan perusahaan regencellbioscience.com RGC|Pendapatan lan volume dodolan AXSM (Axsome Therapeutics, Inc.)|ACADIA Pharma (ACAD) - Total pendapatan perusahaan|XENE - Pendapatan perusahaan|VKTX: Pendapatan perusahaan|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|CPRX (catalystpharma.com) - Pendapatan perusahaan|Dodolan perusahaan DNLI|HRMY: Pendapatan dodolan perusahaan|Dodolan perusahaan BHVN (Biohaven Pharmaceutical)|Total dodolan perusahaan AMLX|Pendapatan lan volume dodolan TRVI (Trevi Therapeutics)|Pendapatan dodolan perusahaan PRAX|Anavex Life Sciences Corp. - Pendapatan lan volume dodolan|Total pendapatan perusahaan CeriBell Inc|Prothena Corporation PLC (PRTA) - Pendapatan perusahaan|Alector - Pendapatan dodolan perusahaan|ANNX (Annexon, Inc.) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Omeros Corp.|Pendapatan perusahaan Neurogene (NGNE)|ACIU: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan VYGR (Voyager Pharma)|Neumora Corp (NMRA) - Total pendapatan perusahaan|SCLX: Dodolan perusahaan|TVGN - Pendapatan lan volume dodolan|ACOG (alphacognition.com) - Dodolan perusahaan|CGTX: Total dodolan perusahaan|IKT (Inhibikase) - Pendapatan lan volume dodolan|Cassava Pharma (SAVA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan ASRT|Dodolan perusahaan coyatherapeutics.com COYA|Pendapatan perusahaan Vistagen VTGN|Pendapatan reged perusahaan Ovid Therapeutics Inc (OVID)|Acumen Pharma - Pendapatan lan volume dodolan|CervoMed Corporation (CRVO) - Dodolan perusahaan|ATHE: Pendapatan lan volume dodolan|Clene - Pendapatan dodolan perusahaan|Pendapatan perusahaan PepGen Inc|JUNS: Pendapatan dodolan perusahaan|Pendapatan perusahaan Relmada (RLMD)|ANVS - Total pendapatan perusahaan|Pendapatan perusahaan Grace Therapeutics GRCE|AIFF: Volume dodolan perusahaan|ANEW Medical, Inc. - Pendapatan lan volume dodolan|Total pendapatan perusahaan NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals Holdings) - Dodolan perusahaan|MetaVia (MTVA) - Pendapatan lan volume dodolan|Pendapatan perusahaan NeurAxis, Inc.|HSDT: Pendapatan dodolan perusahaan|Pendapatan perusahaan Passage Bio, Inc. (PASG)|NEUP - Total pendapatan perusahaan|Pendapatan lan volume dodolan NERV (Minerva Neurosciences Corp)|ATHA - Dodolan perusahaan|Addex Therapeutics - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan ALZN (Alzamend Neuro, Inc.)|cyclerion.com (CYCN) - Pendapatan perusahaan|Protagenic Therapeutics, Inc. - Pendapatan dodolan perusahaan|Pendapatan perusahaan Pasithea Therapeutics Corp|Total pendapatan perusahaan Cortigent Medical CRGT|Pendapatan perusahaan Avenue Therapeutics (ATXI)|Dodolan perusahaan brainstorm-cell.com BCLI|Pendapatan perusahaan Cara Therapeutics CARA|Eliem Therapeutics, Inc. (ELYM) - Total pendapatan perusahaan|Intra-Cellular - Pendapatan lan volume dodolan|Longboard (LBPH) - Dodolan perusahaan|MRNS: Pendapatan lan volume dodolan|Total pendapatan perusahaan nkgenbiotech.com (NKGN)|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Pendapatan perusahaan SAGE|Pendapatan perusahaan Neurotrope (SNPX)|Pendapatan perusahaan TRVN (Trevena Inc)|Vigil Neuroscience, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan WENA|CERE: Dodolan perusahaan
